- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Reviva Pharmaceuticals Holdings, Inc. stock price live, this page displays NASDAQ RVPH stock exchange data. View the RVPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Reviva Pharmaceuticals Holdings, Inc. real time stock price chart below.
What Is the Reviva Pharmaceuticals Holdings, Inc. Stock Price Today?
The Reviva Pharmaceuticals Holdings, Inc. stock price today is 3.016.
What Is the Stock Symbol for Reviva Pharmaceuticals Holdings, Inc.?
The stock symbol for Reviva Pharmaceuticals Holdings, Inc. is ""RVPH.""
What Stock Exchange Does Reviva Pharmaceuticals Holdings, Inc. Trade On?
Reviva Pharmaceuticals Holdings, Inc. is listed and trades on the NASDAQ stock exchange.
Is Reviva Pharmaceuticals Holdings, Inc. a Good Stock to Buy?
Determining whether Reviva Pharmaceuticals Holdings, Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RVPH quote. (ISIN: US76152G2093) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
What Is the Reviva Pharmaceuticals Holdings, Inc. Stock Price Today?
The Reviva Pharmaceuticals Holdings, Inc. stock price today is 3.016.
What Is the Stock Symbol for Reviva Pharmaceuticals Holdings, Inc.?
The stock symbol for Reviva Pharmaceuticals Holdings, Inc. is ""RVPH.""
What Stock Exchange Does Reviva Pharmaceuticals Holdings, Inc. Trade On?
Reviva Pharmaceuticals Holdings, Inc. is listed and trades on the NASDAQ stock exchange.
Is Reviva Pharmaceuticals Holdings, Inc. a Good Stock to Buy?
Determining whether Reviva Pharmaceuticals Holdings, Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RVPH quote. (ISIN: US76152G2093) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
3.016
-0.556(-15.56%)
Real-time Data·
Fair Value
An estimate of a Reviva Pharmaceuticals Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.960
3.520
52 wk Range
0.170
4.198
Earnings results expected in 14 days
1/2
Fair Value
An estimate of a Reviva Pharmaceuticals Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.9603.520
52 wk Range
0.1704.198
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RVPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Reviva Pharmaceuticals Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
95.000
Upside
+3,049.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer’s disease, and Parkinson’s disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Compare RVPH to Peers and Sector
Metrics to compare | RVPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRVPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −6.0x | −0.5x | |
PEG Ratio | −0.01 | 0.05 | 0.00 | |
Price/Book | 4.6x | 1.5x | 2.6x | |
Price / LTM Sales | - | 4.1x | 3.2x | |
Upside (Analyst Target) | - | 98.1% | 51.2% | |
Fair Value Upside | Unlock | 9.6% | 7.3% | Unlock |
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 95.000
(+3,049.87% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.06 / -0.10
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Reviva Pharmaceuticals Holdings (RVPH) Stock Price Today?
The Reviva Pharmaceuticals Holdings stock price today is 3.016 USD.
What Stock Exchange Does Reviva Pharmaceuticals Holdings Trade On?
Reviva Pharmaceuticals Holdings is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Reviva Pharmaceuticals Holdings?
The stock symbol for Reviva Pharmaceuticals Holdings is "RVPH."
What Is the Reviva Pharmaceuticals Holdings (RVPH) Afterhours Price Today? (Afterhours variable test: 0.181) Current Date: Mar 09, 2026
After hours price: 0.181. After hours price change (units): 0.003. Price change percentage: 1.510%
What Is the Reviva Pharmaceuticals Holdings Market Cap?
As of today, Reviva Pharmaceuticals Holdings market cap is 17.640M USD.
What Is Reviva Pharmaceuticals Holdings's Earnings Per Share (TTM)?
The Reviva Pharmaceuticals Holdings EPS (TTM) is -8.680.
When Is the Next Reviva Pharmaceuticals Holdings Earnings Date?
Reviva Pharmaceuticals Holdings will release its next earnings report on Mar 23, 2026.
From a Technical Analysis Perspective, Is RVPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Reviva Pharmaceuticals Holdings Stock Split?
Reviva Pharmaceuticals Holdings has split 1 times.
How Many Employees Does Reviva Pharmaceuticals Holdings Have?
Reviva Pharmaceuticals Holdings has 14 employees.
What is the current trading status of Reviva Pharmaceuticals Holdings (RVPH)?
As of Mar 09, 2026, Reviva Pharmaceuticals Holdings (RVPH) is trading at a price of 3.016 USD, with a previous close of 0.179 USD. The stock has fluctuated within a day range of 2.960 USD to 3.520 USD, while its 52-week range spans from 0.170 USD to 4.198 USD.
What Is Reviva Pharmaceuticals Holdings (RVPH) Price Target According to Analysts?
The average 12-month price target for Reviva Pharmaceuticals Holdings is 95.000 USD, with a high estimate of 320 USD and a low estimate of 20 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +3,049.87% Upside potential.
What Is the RVPH Premarket Price?
RVPH's last pre-market stock price is 3.570 USD. The pre-market share volume is 1,380.000, and the stock has decreased by -0.002, or -0.060%.
What Is the RVPH After Hours Price?
RVPH's last after hours stock price is 0.181 USD, the stock has decreased by 0.003, or 1.510%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.